Lobe Sciences Ltd.
LOBE
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.41M | -3.24M | -2.20M | -2.12M | -2.42M |
| Total Depreciation and Amortization | 41.70K | 62.40K | 80.90K | 73.00K | 52.40K |
| Total Amortization of Deferred Charges | -- | -- | -200.00 | 8.10K | 22.50K |
| Total Other Non-Cash Items | 2.03M | 1.86M | 147.70K | 306.30K | 305.70K |
| Change in Net Operating Assets | 885.40K | 978.90K | 1.18M | 1.56M | 1.46M |
| Cash from Operations | -446.70K | -339.40K | -798.20K | -174.00K | -576.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 563.50K | 563.50K | 337.80K | 67.00K | 337.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 11.20K | 11.20K | 37.70K |
| Repurchase of Common Stock | -- | -- | -- | -11.20K | -11.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -100.00 |
| Cash from Financing | 412.70K | 412.70K | 256.30K | 49.50K | 269.20K |
| Foreign Exchange rate Adjustments | 18.80K | -2.80K | -800.00 | -7.00K | 1.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.10K | 70.60K | -542.70K | -131.50K | -305.80K |